Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026)
Koninklijke Philips' quarterly Liabilities and Shareholders Equity came in at $31.9 billion in Q1 2026, up 11.71% year-on-year from $28.6 billion in Q1 2025, and up 1.78% quarter-over-quarter from $31.4 billion in Q4 2025.
Koninklijke Philips has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $31.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 11.71% year-over-year to $31.9 billion; the trailing twelve-month figure through Mar 2026 stood at $123.9 billion (up 35.78% YoY), and the FY2025 full-year result was $31.4 billion, up 1.29% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $31.9 billion, up from $31.4 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $34.7 billion in Q2 2022, with the low at $28.6 billion in Q1 2025.
- Average Liabilities and Shareholders Equity over 5 years is $31.4 billion, with a median of $31.4 billion recorded in 2025.
- Year-over-year, Liabilities and Shareholders Equity decreased 11.6% in 2022 and grew 11.71% in 2026.
- Tracing PHG's Liabilities and Shareholders Equity over 5 years: stood at $31.3 billion in 2022, then grew by 1.05% to $31.6 billion in 2023, then decreased by 2.13% to $31.0 billion in 2024, then advanced by 1.29% to $31.4 billion in 2025, then advanced by 1.78% to $31.9 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $31.9 billion (Q1 2026), $31.4 billion (Q4 2025), and $30.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 22.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.92 Bn |
| Dec 31, 2025 | 31.36 Bn |
| Sep 30, 2025 | 30.79 Bn |
| Jun 30, 2025 | 29.86 Bn |
| Mar 31, 2025 | 28.58 Bn |
| Dec 31, 2024 | 30.96 Bn |
| Jun 30, 2024 | 31.74 Bn |
| Dec 31, 2023 | 31.64 Bn |
| Jun 30, 2023 | 32.13 Bn |
| Dec 31, 2022 | 31.31 Bn |
| Jun 30, 2022 | 34.67 Bn |
| Dec 31, 2021 | 35.42 Bn |
| Jun 30, 2021 | 34.93 Bn |
| Dec 31, 2020 | 33.04 Bn |
| Jun 30, 2020 | 30.27 Bn |
| Dec 31, 2019 | 29.90 Bn |
| Jun 30, 2019 | 29.61 Bn |
| Dec 31, 2018 | 29.70 Bn |
| Jun 30, 2018 | 29.63 Bn |
| Dec 31, 2017 | 29.81 Bn |
| Sep 30, 2017 | 36.05 Bn |
| Jun 30, 2017 | 32.36 Bn |
| Mar 31, 2017 | 33.95 Bn |
| Dec 31, 2016 | 34.84 Bn |
| Sep 30, 2016 | 34.50 Bn |
| Jun 30, 2016 | 35.12 Bn |
| Mar 31, 2016 | 32.82 Bn |
| Dec 31, 2015 | 33.95 Bn |
| Sep 30, 2015 | 33.58 Bn |
| Jun 30, 2015 | 34.13 Bn |
| Mar 31, 2015 | 35.92 Bn |
| Dec 31, 2014 | 35.44 Bn |
| Sep 28, 2014 | 37.11 Bn |
| Jun 29, 2014 | 35.20 Bn |
| Mar 30, 2014 | 35.59 Bn |
| Dec 31, 2013 | 36.15 Bn |
| Sep 29, 2013 | 36.20 Bn |
| Jun 30, 2013 | 36.07 Bn |
| Mar 31, 2013 | 37.93 Bn |
| Dec 31, 2012 | 37.71 Bn |
| Sep 30, 2012 | 36.75 Bn |
| Dec 31, 2011 | 39.62 Bn |
| Dec 31, 2010 | 43.82 Bn |
| Dec 31, 2009 | 45.08 Bn |
| Sep 27, 2009 | 42.13 Bn |
| Jun 28, 2009 | 39.66 Bn |
| Mar 29, 2009 | 41.79 Bn |